BMI1P1 and acute myeloid leukemia: It revealed that BMI1P1 expression could serve as a valuable biomarker for distinguishing whole AML patients from control subjects (AUC = 0.895, 95% CI: 0.835–0.954, P < 0.001) (Figure 3A).